Biolux Research Announces Health Canada Regulatory Approval for its OsseoPulse Bone Regeneration

VANCOUVER, BC – Biolux Research Ltd. announced today that it has received approval from Health Canada to market the OsseoPulse Bone Regeneration System in Canada. The OsseoPulseTM is classified by Health Canada as a Class II medical device, and received a Medical Device Licence for the system and its components. The licence was applied for in partnership with StarFish Medical of Victoria, BC.

“Issue of the licence from Health Canada is a key milestone in our plan to commercialize the OsseoPulseTM product. It enables marketing and sales of the product directly in Canada, as well as establishes county of origin approval to support export to overseas markets,” states Kevin Strange, President and CEO of Biolux. “We look forward to introducing the OsseoPulseTM to the Canadian market at dental implant and regeneration conferences in the third quarter of this year, and to the Korean market with our distribution partner DIO Implant.”

About Biolux Research
Biolux Research Ltd. is a world leader in the development of light activated bone regeneration systems for dentistry. Biolux focuses on product development, clinical and basic research and is well positioned to release its OsseoPulse? system to the marketplace in 2008. Its proprietary, patent pending OsseoPulse? Bone Regeneration System is premised on a vision to transform the practice of implantology and oral surgery in dentistry by accelerating implant integration and bone regeneration in a safe, effective and non-invasive approach. www.bioluxresearch.com

About DIO Implant
DIO Implant is a subsidiary of Dong Seo Inc. (DSI), a KOSDAQ exchange listed company with a market value approximately 160 Million US dollars. DIO implant is one of the best selling implant systems in Korea. DSI supplies DIO dental implant systems to more than 30 dental hospitals and 2,000 dental clinics and has over 13% of Korean domestic market share. DSI also exports the DIO dental implant system to number of countries including Australia, Vietnam, China, Mexico and the USA. For more information please visit: www.dio.co.kr/en/

About StarFish Medical
Starfish Medical is a leading specialist firm in contract medical device development and manufacturing. For over 10 years StarFish Medical has designed, developed and manufactured sophisticated medical devices for a select clientele. StarFish is an ISO 13485 certified developer and manufacturer of high technology medical products on contract and joint venture basis. www.starfishmedical.com

For more information
Kevin Strange
President & CEO
Biolux Research Ltd.
+1 (250) 686-1120
k.strange@bioluxresearch.com

Share on Facebook0Share on LinkedIn0Tweet about this on Twitter